Pridgen William 4
4 · Virios Therapeutics, Inc. · Filed May 19, 2022
Insider Transaction Report
Form 4
Pridgen William
Director
Transactions
- Purchase
Common Stock
2022-05-18$4.50/sh+241$1,085→ 36,710 total(indirect: 401 (k) Account)
Holdings
- 709,234
Common Stock
Footnotes (1)
- [F1]The number of shares reported are indirectly held within the Reporting Person's 401(k) account and are invested in the Tuscaloosa Surgical Assoc PC 401k U/A Dtd Jan 1, 2001 of which the Reporting Person is trustee.